Functional Consequences of Mutations in the Myosin Regulatory Light Chain Associated with Hypertrophic Cardiomyopathy

نویسندگان

  • Priya Muthu
  • Wenrui Huang
  • Katarzyna Kazmierczak
  • Danuta Szczesna-Cordary
چکیده

Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ventricular wall thickening, myofilament disarray and abnormal echocardiography findings. Molecular genetic studies have defined FHC as a disease of the sarcomere caused by mutations in all major sarcomeric proteins, such as ┚-myosin heavy chain (44%), myosin binding protein C (35%), regulatory light chain (2%), essential light chain (1.6%), ┙-tropomyosin (2.5%), troponin T (7%), troponin I (5%), troponin C (~1%), ┙actin (1%), and titin (<1%) (Alcalai et al., 2008). Although mutations in the regulatory light chain (RLC) of myosin are rare, they are of great significance given the importance of RLC for muscle contraction and heart function. The RLC plays an essential structural and functional role by supporting the architecture of the myosin neck region and fine-tuning the kinetics of the actin-myosin interaction (Morano, 1999; Szczesna, 2003). As shown in Fig. 1, the RLC wraps around the ┙-helical neck region of the myosin head by binding to a 35 amino acid IQ motif in the myosin heavy chain (MHC) (Rayment et al., 1993). This domain of MHC is anticipated to act as a lever arm, amplifying small conformational changes that originate at the catalytic site into large movements thus allowing myosin to generate motion and force (Geeves & Holmes, 2005; Lowey et al., 1993). Furthermore, this neck region has been proposed to serve as the compliant element of the myosin cross-bridge with the RLC contributing to the stiffness of the lever arm (Howard & Spudich, 1996; Pant et al., 2009). Two functionally important domains of the RLC molecule include its Ca2+-Mg2+ binding site, comprised of the Nterminal helix-loop-helix EF-hand Ca2+ binding motif, and a highly conserved N-terminal phosphorylatable serine constituting a myosin light chain kinase (MLCK)-dependent phosphorylation site. The N-terminal divalent cation-binding site of the RLC is thought to be occupied by Mg2+ when muscles are in the relaxed state and may become partially saturated with Ca2+, depending on the length of the [Ca2+] transient (Robertson et al., 1981). The MLCK phosphorylation site of RLC is also of great structural and functional importance. Phosphorylation of this site in smooth muscle activates contraction (Hartshorne & Mrwa, 1982; Small & Sobieszek, 1977; Sobieszek, 1977). In skeletal and cardiac muscle, Ca2+-

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy is a multigenetic cardiac disease with autosomal dominant pattern of inheritance and incomplete penetrance, with the exclusion of those cases caused by mutations in the mitochondrial genome. The disease is usually caused by mutations in several sarcomeric contractile protein genes. Mutations have been found in four genes that encode components of the thick filament: ...

متن کامل

In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy.

Mutations in cardiac motor protein genes are associated with familial hypertrophic cardiomyopathy. Mutations in both the regulatory (Glu22Lys) and essential light chains (Met149Val) result in an unusual pattern of hypertrophy, leading to obstruction of the midventricular cavity. When a human genomic fragment containing the Met149Val essential myosin light chain was used to generate transgenic m...

متن کامل

Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Hypertrophic cardiomyopathy is characterized by left and/or right ventricular hypertrophy, which is usually asymmetric and involves the interventricular septum. Typical morphological changes include myocyte hypertrophy and disarray surrounding the areas of increased loose connective tissue. Arrhythmias and premature sudden deaths are common. Hypertrophic cardiomyopathy is familial in the majori...

متن کامل

Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

In 10-30% of hypertrophic cardiomyopathy kindreds, the disease is caused by > 29 missense mutations in the cardiac beta-myosin heavy chain (MYH7) gene. The amino acid sequence similarity between chicken skeletal muscle and human beta-cardiac myosin and the three-dimensional structure of the chicken skeletal muscle myosin head have provided the opportunity to examine the structural consequences ...

متن کامل

In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament.

In the 20 years since the discovery of the first mutation linked to familial hypertrophic cardiomyopathy (HCM), an astonishing number of mutations affecting numerous sarcomeric proteins have been described. Among the most prevalent of these are mutations that affect thick filament binding proteins, including the myosin essential and regulatory light chains and cardiac myosin binding protein (cM...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012